相关实验视频

Updated: Jun 16, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

工程线粒体具有强大的抗瘤免疫力,作为癌症疫苗平台

Jingwen Luo¹, Fei Mo^1,2, Zhe Zhang^1,3

¹Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Cellular & molecular immunology

|August 20, 2024

概括

携带癌症抗原的工程线粒体有效地激活免疫细胞,并显示出强大的抗瘤作用. 这种新的平台为开发先进的癌症疫苗和其他免疫疗法提供了一个有希望的方法.

科学领域:

免疫学免疫学免疫学
生物技术是生物技术.
癌症研究癌症研究

背景情况:

线粒体具有独特的特性,包括损伤相关分子模式 (DAMPs),可促进免疫细胞的吸收和激活.
有效的疫苗设计依赖于最佳的抗原输送和强大的辅助剂的加入.

研究的目的:

开发一种新的癌症疫苗平台,使用工程化线粒体进行抗原输送.
评估基于线粒体的疫苗的抗瘤疗效和免疫激活潜力.

主要方法:

模型抗原的融合蛋白 (卵泡蛋白,与铁酶相关的蛋白2) 与线粒体信号被合成.
一个lentiviral系统被用来产生抗原丰富的线粒体 (OVA-MITO,TRP2-MITO).
这些工程线粒体作为预防和治疗癌症疫苗的有效性在小鼠模型中进行了评估.

主要成果:

工程线粒体疫苗在预防和治疗环境中显示出显著的抗瘤效应.
OVA-MITO和TRP2-MITO有效地招募和激活树突细胞 (DCs),诱导瘤特异性细胞介导免疫.
电流激活严重依赖于托尔类受体2 (TLR2) 途径和心血管蛋白.

结论:

工程化线粒体作为有效的,免疫刺激的载体,用于抗原递送,准局部DCs.
该平台建立了一种多功能方法,用于构建用于各种疾病的工程线粒体疫苗,包括癌症.
线粒体心脏脂蛋白在这些疫苗中介于TLR2的DC激活中起着关键作用.

关键词:

反瘤免疫力抗瘤免疫力卡迪奥利平因 (cardiolipin) 是一种心脏蛋白质.线粒体疫苗线粒体疫苗在TLR2中,它是TLR2.

更多相关视频

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...